AI assistant
Sending…
RESMED INC — Director's Dealing 2025
Nov 18, 2025
30071_dirs_2025-11-18_41700e3c-3639-41d5-9a28-e01cdefef156.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2025-11-14
Reporting Person: FARRELL PETER C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-14 | ResMed Common Stock | M | 11442 | $101.64 | Acquired | 77552 | Direct |
| 2025-11-14 | ResMed Common Stock | F | 7314 | $244.46 | Disposed | 70238 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-14 | ResMed Common Stock Options | $101.64 | M | 11442 | Disposed | 2025-11-14 | ResMed Common Stock (11442) | Direct |
Footnotes
F1: Transaction represents Options automatically exercised pursuant to the award terms. Options are vested in full.
F2: Disposition to issuer for tax withholding and cost to exercise the options granted on 11/14/2018.
F3: Transaction represents Options automatically exercised pursuant to the award terms. Options are vested in full.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29